Frontlight ResearchEarly access
Trial site
EMC Silesia Sp. z o.o.
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease2 trials
- Atrial fibrillation1 trial
- Lupus (SLE)1 trial
- Obesity1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- Amgen Inc.1 trial
- Biogen1 trial
- Bristol-Myers Squibb1 trial
- Celltrion Inc.1 trial
- Ribocure Pharmaceuticals AB1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Atrial fibrillation1 recruiting
Closed trials
Completed
Active, not recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026